PPARGC1A and chronic kidney disease: A clinical study in diabetic patients with CKD has shown that PGC-1α levels are significantly decreased in cortical tubulointerstitial samples, which is associated with the reduction of mitochondrial proteins and mtDNA contents, an indirect indication of global suppression of mitochondrial biogenesis (Sharma et al., 2013).